Please login to the form below

Not currently logged in
Email:
Password:

Skin and Blister

This page shows the latest Skin and Blister news and features for those working in and with pharma, biotech and healthcare.

Abeona Therapeutics’ rare disease phase 3 trial halted due to FDA concerns

Abeona Therapeutics’ rare disease phase 3 trial halted due to FDA concerns

The condition is a life-threatening rare skin disease, which is incurable and causes the skin to blister due to a lack of collagen that renders the skin very fragile. ... This gene is missing in RDEB patients, and can restore normal collagen production

Latest news

  • New healthcare comms agency launched in UK New healthcare comms agency launched in UK

    Skin and Blister co-founded by Fiona Edwards and Katie Langdon. Healthcare communications specialists Fiona Edwards and Katie Langdon have launched a new creative agency specialising in pharmaceutical marketing services. ... With Skin and Blister, you

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Apex.co.uk Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

Pharma index map
The 2019 CPhI Pharma Index Report
Examining this year’s industry performance...
Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...

Infographics